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Abstract
Background: Recent scientific data support that the mode of conception and delivery
may influence epigenetic regulation and therefore embryo development. Octamer-binding
transcription factor 4-B1 (OCT4B1), a novel variant of OCT4 with yet unknown biological function,
is suggested to have a potential role in mediating cellular stress response. Furthermore,
Insulinlike Growth Factor 2 (IGF2), Mesoderm-specific Transcript (MEST) and paternally
expressed gene 10 (PEG10) are genes known as imprinted and are regulated via means of
epigenetic regulation. The influence of delivery mode and conception on epigenetic regulation
is an active research field.
Objective: Our aim was to correlate the expression level of Oct4B1 and the expression and
methylation level of IGF2, MEST, and PEG10 imprinted genes with the mode of delivery and
conception in the umbilical cord blood of newborns.
Materials and Methods: Samples of umbilical cord blood from infants born after vaginal delivery,
caesarean section (CS) with the infant in cephalic position and CS due to breech position were
examined. Furthermore, the investigation included infants conceived throughmeans of assisted
reproductive technology.
Results: No statistically significant differences were found in mRNA expression levels between
different modes of conception and delivery (p = 0.96). Oct4B1, IGF2, MEST, and PEG10
expression levels do not seem to be significantly affected by different modes of conception
and delivery.
Conclusion: These results indicate that the expression and methylation patterns of Oct4B1,
IGF2, MEST and PEG10 in umbilical cord blood are not affected by the conception and delivery
mode.
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1. Introduction
Vaginal delivery (VD) exposes infants to various
stressors absent during caesarean section (CS),
such as the secretion of catecholamines and
cortisol, which trigger hormonal cascades in
order to prepare the infant for life after birth (1).
Furthermore, the artificial interventions employed
during assisted reproductive technologies
(ARTs), coincide with the embryos’ epigenetic
reprogramming, thus leading possibly to
aberrant establishment and maintenance of
genomic imprints and an increase in imprinting
disorders (2-5). On the other hand, concerning
cellular stress, the octamer-binding transcription
factor 4-B1 isoform, (Oct4B1), has emerged
as a possible cell stress marker (6). This
isoform has been found to be an emergent
marker of stemness in embryonic cells and
is also implicated in apoptosis and probably
in cancer (7-10). In the present study, Oct4B1
was selected to be studied because of its
putative role in cellular stress response. This
is the first study conducted in umbilical cord
blood (UCB) concerning Oct4B1. Other genes
susceptible to epigenetic modification upon
stress exposure are Insulin Growth Factor 2
(IGF2), Mesoderm-Specific Transcript (MEST),
and Paternally Expressed Gene 10 (PEG10).
These genes affect fetal growth and their
disruption is linked to metabolic disorders,
cognitive impairment, low birth weight, and
some types of cancer (11-13). These genes
were selected to be studied because of their
crucial role in fetal development, as they control
embryonic and placental growth. Furthermore,
these imprinted genes are responsive to
different in utero environments and thus
may mediate adverse environmental signals
to the embryo during pregnancy. There are
contradictory results in literature concerning the
effect of ART on these genes. Lastly, there
are no previous reports of the expression
of these genes in embryos with breech
presentation.
Given that various environmental factors
and stressors can affect the epigenetic
processes, concerns are raised about the
implications of the increasing prevalence in
elective CS deliveries and the use of ART.
Our aim was to investigate the role of different
modes of conception and delivery as possible
environmental stressors on epigenetic regulation
and stress response. Therefore, we evaluated the
expression level of Oct4B1 and the expression
and methylation status of IGF2, MEST, and
PEG10 imprinted genes in UCB samples of
newborns.
2. Materials and Methods
2.1. Sampling method
In this cohort study, 40 participants were
enrolled whose UCB samples were collected
during the time of their delivery. The samples
were subdivided into four groups that comprised
of 10 participants each. The extremely strict
inclusion criteria did not allow for a larger
sample size to be collected. This may be a
disadvantage for the statistical analysis of the
results, but it reflects a very homogenous and
carefully designed sample population. The
groups examined were VD (control group), CS
with cephalic projection of the embryo, and CS
with breech embryo projection. Additionally,
the fourth group consisted of infants conceived
through ART and delivered through caesarian
section.
The eligibility for participation included
uncomplicated full-term deliveries (≥ 37 wk) of
healthy parents with an existing full medical
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record and supervision of the pregnancy by an
obstetrician. On the other hand, the exclusion
criteria included positive smoking status, chronic
or acute diseases, twin gestations, non-compliance
to the required medical tests during pregnancy,
and pregnancies with embryos presenting
chromosomal or anatomical abnormalities. All
biospecimens collected were done so with
the participant’s informed written consent after
having secured permission from the Scientific
Committee of Papageorgiou General Hospital
of Thessaloniki, the Bioethics Committee of
the School of Medicine of Aristotle University of
Thessaloniki, and from theHellenic Data Protection
Authority.
2.2. Quantitative real-time polymerase
chain reaction (qRT-PCR)
Total RNA was extracted from leucocytes using
TRIZOL reagent (Invitrogen, USA), according to
the manufacturer’s instructions. RNA samples were
treated with TURBO DNA-freeTM DNase (Ambion,
Life Technologies, USA). A no-reverse transcription
(no-RT) control was used for each sample to
exclude any potential non-specific amplification
of genomic DNA. The SuperScriptTM First-Strand
Synthesis System (Invitrogen, USA) was used
to reverse transcribe total RNA with random
hexamer primers. Quantitative Real-Time PCR
employed TaqManTM Gene Expression MasterMix
reagent (Thermo Scientific, USA) and TaqManTM
Gene Expression Assays for evaluation of Beta-
2 Microglobulin (B2M, endogenous control) IGF2,
MEST, and PEG10 transcription. The primers
for Oct4B1 were previously described (Table I).
Quantification of the results was performed using
the 2−ΔΔCt method after normalization against
B2M.
2.3. Methylation-specific PCR
For DNA extraction, DNA Mini Kit (Qiagen,
Netherlands) was used. DNA recovered from
the aforementioned process was chemically
converted using EpiTectPlus DNA Bisulfite
Kit (Qiagen, Netherlands), in order to turn
unmethylated cytosines to uracil for detection
by methylation-specific PCR. Next, the bisulfite-
treated DNA was subjected to PCR for detection
of the methylated and unmethylated MEST,
IGF2, and PEG10 alleles (Table II). Samples
containing no DNA were used as a negative
control, whereas for positive control, bisulfite-
treated DNA from peripheral blood was
used.
Table I. Primers used for qRT-PCR





Oct4B1 F: 5’ GGGTTCTATTTGGTGGGTTCC 3’R: 5’ TCCCTCTCCCTACTCCTCTTCA 3’ 128bp
Primers for Beta-2 Microglobulin (B2M), Insulin Growth Factor 2 (IGF2), Mesoderm-Specific Transcript (MEST), and Paternally
Expressed Gene 10 (PEG10) were commercially available from Thermo Fisher Scientific. Primers for Oct4B1 according to
Farashahi Yazd E and colleagues (7). B2M: 81bp, IGF2: 93bp, MEST: 93bp, PEG10: 87bp, OCT4B1: 128bp
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Table II. Sequence and characteristics of methylation-specific PCR primers for MEST-, PEG10-, and IGF2-imprinted genes
Gene name Sequence (5’→3’) Tm (°C) GC content Product
MEST meth/prF TAGTTGCGTTTCGTAAGGTAGTGTC (25) 61.3 44.0%
MEST meth/prR ACACAATCCTCCGCTCGCCTA (21) 61.8 57.1%
291bp
MEST unmeth/prF GTGGTAGTTGTGTTTTGTAAGTGTAGTGTT (30) 62.7 36.7%
MEST unmeth/prR CACACAATCCTCCACTCACCTACA (24) 62.7 50.0%
296bp
PEG10 meth/prF AGGTTCGTTGAGCGGGTTGTCGTTCG (26) 64.7 57.7%
PEG10 meth/prR TCCCGATAAACACGAAAAATAAACG (25) 54.1 36.0%
184bp
PEG10 unmeth/prF AGGTTTGTTGAGTGGGTTGTTGTTTG (26) 58.4 42.3%
PEG10 unmeth/prR TCCCAATAAACACAAAAAATAAACA (25) 50.2 24.0%
184bp
IGF2 meth/prF TTAATTGGGGTTCGTTCG (18) 51.4 44.4%
IGF2 meth/prR CCCGACCTAAAAATCTAATACGA (23) 57.1 39.1%
118bp
IGF2 unmeth/prF GGTTTGTTTGTGGAAATGTTTT (22) 52.8 31.8%
IGF2 unmeth/prR CCCAACCTAAAAATCTAATACAA (23) 53.5 30.4%
110bp
Primers MEST: Kosaki et al (14). Primers IGF2: Dimitriadou et al (15). Primers PEG10: Designed for the first CpG-island of the
gene. TM: Meth 57°C/unmeth 60°C, GC: 44%, Meth: Methylated allele, Unmeth: Unmethylated allele, prF: Primer forward, prR:
Primer reverse, MEST: Mesoderm-specific transcript, PEG: Paternally expressed gene 10, IGF2: Insulin-like Growth Factor 2
2.4. Ethical considerations
All procedures performed in studies involving
human participants were in accordance with the
ethical standards of the Scientific Committee of
Papa Georgiou General Hospital of Thessaloniki
(reference number: 157/27.06.12), the Bioethics
Committee of the School of Medicine of Aristotle
University of Thessaloniki (reference number: 1/8-
11-2012), and of the Hellenic Data Protection
Authority (reference number: 1145) and with the
1964Helsinki Declaration and its later amendments
or comparable ethical standards. In addition,
a written informed consent was obtained from
individual participants included in the study.
2.5. Statistical analysis
Data were analyzed using the IBM SPSS
Statistics version.24 (SPSS Inc., Chicago,
Illinois, USA) program. Demographic data were
normally distributed (based on Shapiro test for
normality) and one-way ANOVA-test was used
for quantitative variables (maternal age, maternal
weight, gestational week, and birth weight) and
χ2-test for qualitative variables (gender of the
newborns and ratio of primiparae women). The
gene expression results were evaluated through
non-parametrical tests due to the small sample
size, and more specifically the Kruskal-Wallis test
was employed to compare Oct4B1, IGF2, MEST,
and PEG10 expression between the four groups.
Results were deemed significant only when p <
0.05.
3. Results
As mentioned above, 40 participants were
enrolled whose UCB samples were collected
during the time of their delivery (Table III).
Quantitative Real-time PCR revealed no statistically
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significant differences at the transcriptional level
between the VD, CS, and ART groups for Oct4B1
(p = 0.58), IGF2 (p = 0.96), MEST (p = 0.75), and
PEG10 (p = 0.37) (Figure 1). PEG10 exhibited a non-
significant trend for up regulation (p = 0.089) in
the group of cephalic presentation CS compared to
the VD group. Methylation-Specific PCR products
were subjected to gel electrophoresis in order
to validate the presence of both methylated
and unmethylated alleles for IGF2, MEST, and
PEG10 for all 40 samples (Figure 2). Methylation
analysis was not possible for Oct4B1 due to the
existence of alternative promoters for this isoform,
incommoding primer design (16). Methylation status
is in agreement with non-statistical differences in
expression.












Maternal age* 32.3 ± 3.37 33.6 ± 3.72 31 ± 4.35 35.2 ± 3.12 0.084
Maternal weight* 74.6 ± 4.97 73.3 ± 4.52 74.3 ± 5.05 73.4 ± 3.44 0.89
Gestational week* 38.7 ± 1.05 37.9 ± 0.65 38.3 ± 1.06 38 ± 0.74 0.142
Primiparae women 50% 40% 60% 70% 0.57+
Birthweight* (kg) 3.21 ± 0.38 3.22 ± 0.39 3.34 ± 0.44 3.02 ± 0.18 0.289
Gender (male) 40% 50% 40% 60% 0.776+
*Data presented as Mean ± SD. One-way ANOVA, +x2-test for qualitative variables
Figure 1. Expression of IGF2, MEST, PEG10, and Oct4B1 genes in UCB from infants derived through vaginal delivery (VD),
caesarean section with cephalic embryo projection (CSCP), caesarean section with breech embryo projection (CSBP), and assisted
reproduction technologies (ARTs). Each group consists of 10 samples. Samples were normalized against B2M and compared with
the control group. Median values ± SD presented.
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Figure 2. Methylation analysis of IGF2 (A), MEST (B), and PEG10 (C), respectively, for some samples of all groups, including
positive (C+) and negative (C-) controls. VD: Vaginal delivery, CSCP: Caesarean section with cephalic embryo projection, CSBP:
Caesarean section with breech embryo projection, ART: Assisted reproduction technologies, L: Ladder 100bp, M: Methylated
allele, U: Unmethylated allele. PCR product sizes: IGF2: 118bp (M), 110bp (U), MEST: 291 (M), 296bp (U), PEG10: 184bp (M), 184bp
(U).
4. Discussion
It is assumed that imprinted genes can serve
as environmental sensors, since they can be
responsive to environmental stressors and
alter their expression and/or methylation during
specific developmental stages.
In the current study, we investigated the effect
of the conception and delivery mode, which are
considered potential environmental stressors, on
the expression and methylation levels of three
imprinted genes. Furthermore, we evaluated their
effect on the expression of Oct4B1 isoform, a
potential stress-response marker.
In our study, it appears that different
modes of conception and delivery do not
alter significantly the mRNA expression levels
for Oct4B1, IGF2, MEST, and PEG10 in UCB.
This could be attributed not only to the small
sample size available, but also to the extremely
strict inclusion criteria, excluding any kind of
fetal abnormality, complicated pregnancies,
mothers with diagnosed health conditions, and
unsupervised pregnancies.
To date, to the best of our knowledge, no
other reports exist in literature investigating the
expression levels of the Oct4B1 isoform in UCB.
Oct4B1 is not only a newly discovered variant of
Oct4 family that bestows stemness qualities in
cell expressing it, but also seems to serve an
anti-apoptotic function in a multitude of cancer
cell lines (9, 10, 17, 18). Furthermore, Oct4B1
warrants further investigation as a regulator of
cellular stress response since it plays a role in
the regulation of HSP40 family of chaperones (17).
The implications of this regulation are not clear
at the moment, but it is possible that Oct4B1
might modulate globally the stress response
since the HSP40 family constitutes the most
diverse and largest category of HSPs and its
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members are known to interact with other actively
researched HSP families such as HSP70 and
HSP90 (19). Different stress conditions during
CS and ART could probably result in alterations
in Oct4B1 expression levels. However, this was
not observed in our study, indicating that the
stress variations during different conception and
delivery modes are not capable of affecting
Oct4B1 expression.
Furthermore, this is the first study on the
expression and methylation of those genes
that correlate them to embryo presentation
during CS, either cephalic or breech. Such a
distinction is of importance since the positioning
of the embryo can indicate maturity prior to
delivery and either excessive or suboptimal
levels of stress could possibly interfere with
methylation and future health outcomes.
Interestingly, in our study, there was a trend
for increased expression of PEG10 in the
CSCP group, a finding that warrants further
investigation in broader sample studies. As far
as the ART group is concerned, our results
are consistent with previous studies, indicating
stability in the expression and DNA methylation
levels of the aforementioned imprinted genes.
However, there are other studies reporting
altered DNA methylation and expression levels
of these genes after ART treatments. These
contradictory results can be attributed to
different ART protocols, variation in sample
size, sample homogeneity, and different analysis
methods.
Furthermore, there are also other mechanisms
that maintain imprints, such as histone
modifications and long non-coding RNAs,
which should also be considered as a possible
explanation to the variation of results found
between studies. It remains also unclear whether
the parental underlying sub-fertility Per se can act
as the causal factor of the higher complication
prevalence observed in the results of some
reports of ART-conceived children. Lastly, the
existence of an imprinted gene network could also
explain the heterogeneity of the reported results.
This theory was first described in animal reports
(20, 21), but many scientists believe that it also
refers to humans (22-24). According to this theory,
the imprinted gene network includes hundreds
of imprinted genes with similar roles controlling
essential functions, such as fetal nutrition and
growth. Thus, the inappropriate function of some
imprinted genes can be compensated by the
expression of others with similar role.
All evidence shows that it is necessary to
understand the health risks and the underlying
molecular mechanisms of ART interventions in
order to increase the safety of these techniques.
Thus, the contradictory literature results call for
caution and for larger studies. The current study is
exploratory in nature, utilizing well-characterized
groups as far as the medical history of the
participants and the medical supervision during
pregnancy is concerned. It can be considered
though as a starting point for more resolving the
role of imprinted genes and Oct4B1 isoform on
the regulation of human reproduction. Due to the
limitation of the sample size, further studies are
needed to evaluate these results.
5. Conclusion
The results indicate that different modes of
conception and delivery do not affect the mRNA
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expression levels of Oct4B1, IGF2, MEST, and
PEG10 in UCB. These results are the first
reported in cephalic and breech presentation
CS concerning these specific genes. Additionally,
methylation analysis revealed the presence of
both methylated and unmethylated alleles for the
above aforementioned imprinted genes, with no
methylation differences reported between groups.
Methylation status of all genes is in consistence
with non-statistical differences in expression.
Methylation analysis was not possible for Oct4B1
due to the existence of unknown alternative
promoters for this isoform. While our study found
no effect of the mode of conception and delivery
on the expression of Oct4B1, IGF2, MEST, and
PEG10 in UCB, the expression of the genes in
question should be investigated further. As far
as the ART group is concerned, our results are
consistent with some previous reports.
However, there are other studies reporting
altered DNA methylation and expression of
these genes after ART manipulations. These
contradictory literature results call for caution
and for larger studies. Differences may become
apparent utilizing larger sample sizes, keeping
though in mind that excellent characterization
of the groups examined (medical history,
supervision, etc.) should not be compromised
for achieving the desired sample size. This
would ensure that the observed effect can be
strongly correlated to the mode of conception
and delivery, rather than confounding variables.
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